カテゴリ： 世界, 医療/バイオ, QYResearch

ポイントオブケア（POC）がんスクリーニングの世界市場2023年：遺伝子検査、画像検査、その他

■ 英語タイトル：Global Point-of-care Cancer Screening Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA6561）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA6561
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ポイントオブケア（POC）がんスクリーニングの世界市場2023年：遺伝子検査、画像検査、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はポイントオブケア（POC）がんスクリーニングのグローバル市場について調査・分析し、世界のポイントオブケア（POC）がんスクリーニング市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（遺伝子検査、画像検査、その他）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Hologic Corporation、Abbott Laboratories、Qiagen N.V.、F Hoffmann-La Roche、BD、Quest Diagnostics、OncoHealth Corp、Danaher、NOVIGENIX SA、Quidel Corporationなどが含まれています。ポイントオブケア（POC）がんスクリーニングのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ポイントオブケア（POC）がんスクリーニング市場規模を算出する際に考慮しました。

・ポイントオブケア（POC）がんスクリーニング市場の概要
- ポイントオブケア（POC）がんスクリーニングの種類別セグメント
- 世界のポイントオブケア（POC）がんスクリーニング市場規模：タイプ別分析（遺伝子検査、画像検査、その他）
- ポイントオブケア（POC）がんスクリーニングの用途別セグメント
- 世界のポイントオブケア（POC）がんスクリーニング市場規模：用途別分析（病院、クリニック、その他）
- 世界のポイントオブケア（POC）がんスクリーニング市場規模予測（2018年-2029年）

・ポイントオブケア（POC）がんスクリーニング市場の成長トレンド
- ポイントオブケア（POC）がんスクリーニングの地域別市場規模（2018年-2029年）
- ポイントオブケア（POC）がんスクリーニング市場ダイナミクス
- ポイントオブケア（POC）がんスクリーニングの業界動向
- ポイントオブケア（POC）がんスクリーニング市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：遺伝子検査、画像検査、その他
- 世界のポイントオブケア（POC）がんスクリーニングのタイプ別市場規模（2018年-2023年）
- 世界のポイントオブケア（POC）がんスクリーニングのタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、クリニック、その他
- 世界のポイントオブケア（POC）がんスクリーニングの用途別市場規模（2018年-2023年）
- 世界のポイントオブケア（POC）がんスクリーニングの用途別市場規模（2024年-2029年）

・ポイントオブケア（POC）がんスクリーニングの地域別市場規模
- 北米のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- 米国のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- ヨーロッパのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- アジア太平洋のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- 中国のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- 日本のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- 韓国のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- インドのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- オーストラリアのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- 中南米のポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）
- 中東・アフリカのポイントオブケア（POC）がんスクリーニング市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Hologic Corporation、Abbott Laboratories、Qiagen N.V.、F Hoffmann-La Roche、BD、Quest Diagnostics、OncoHealth Corp、Danaher、NOVIGENIX SA、Quidel Corporation

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Point-of-care Cancer Screening market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Point-of-care Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Point-of-care Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Point-of-care Cancer Screening in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Point-of-care Cancer Screening include Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche, BD, Quest Diagnostics, OncoHealth Corp, Danaher and NOVIGENIX SA, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-of-care Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-care Cancer Screening.
The Point-of-care Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point-of-care Cancer Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-care Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Hologic Corporation
Abbott Laboratories
Qiagen N.V.
F Hoffmann-La Roche
BD
Quest Diagnostics
OncoHealth Corp
Danaher
NOVIGENIX SA
Quidel Corporation
Segment by Type
Genetic Screening
Image Screening
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point-of-care Cancer Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genetic Screening
1.2.3 Image Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global Point-of-care Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Cancer Screening Market Perspective (2018-2029)
2.2 Point-of-care Cancer Screening Growth Trends by Region
2.2.1 Global Point-of-care Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point-of-care Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Point-of-care Cancer Screening Forecasted Market Size by Region (2024-2029)
2.3 Point-of-care Cancer Screening Market Dynamics
2.3.1 Point-of-care Cancer Screening Industry Trends
2.3.2 Point-of-care Cancer Screening Market Drivers
2.3.3 Point-of-care Cancer Screening Market Challenges
2.3.4 Point-of-care Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Cancer Screening Players by Revenue
3.1.1 Global Top Point-of-care Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Point-of-care Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Point-of-care Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Cancer Screening Revenue
3.4 Global Point-of-care Cancer Screening Market Concentration Ratio
3.4.1 Global Point-of-care Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Cancer Screening Revenue in 2022
3.5 Point-of-care Cancer Screening Key Players Head office and Area Served
3.6 Key Players Point-of-care Cancer Screening Product Solution and Service
3.7 Date of Enter into Point-of-care Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Cancer Screening Breakdown Data by Type
4.1 Global Point-of-care Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Point-of-care Cancer Screening Forecasted Market Size by Type (2024-2029)
5 Point-of-care Cancer Screening Breakdown Data by Application
5.1 Global Point-of-care Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Point-of-care Cancer Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Point-of-care Cancer Screening Market Size (2018-2029)
6.2 North America Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point-of-care Cancer Screening Market Size by Country (2018-2023)
6.4 North America Point-of-care Cancer Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-care Cancer Screening Market Size (2018-2029)
7.2 Europe Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point-of-care Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Point-of-care Cancer Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Cancer Screening Market Size (2018-2029)
8.2 Asia-Pacific Point-of-care Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-care Cancer Screening Market Size (2018-2029)
9.2 Latin America Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point-of-care Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Point-of-care Cancer Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Cancer Screening Market Size (2018-2029)
10.2 Middle East & Africa Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic Corporation
11.1.1 Hologic Corporation Company Detail
11.1.2 Hologic Corporation Business Overview
11.1.3 Hologic Corporation Point-of-care Cancer Screening Introduction
11.1.4 Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.1.5 Hologic Corporation Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Point-of-care Cancer Screening Introduction
11.2.4 Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Detail
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Point-of-care Cancer Screening Introduction
11.3.4 Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.3.5 Qiagen N.V. Recent Development
11.4 F Hoffmann-La Roche
11.4.1 F Hoffmann-La Roche Company Detail
11.4.2 F Hoffmann-La Roche Business Overview
11.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Introduction
11.4.4 F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.4.5 F Hoffmann-La Roche Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Point-of-care Cancer Screening Introduction
11.5.4 BD Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.5.5 BD Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Detail
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Point-of-care Cancer Screening Introduction
11.6.4 Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.6.5 Quest Diagnostics Recent Development
11.7 OncoHealth Corp
11.7.1 OncoHealth Corp Company Detail
11.7.2 OncoHealth Corp Business Overview
11.7.3 OncoHealth Corp Point-of-care Cancer Screening Introduction
11.7.4 OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.7.5 OncoHealth Corp Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Point-of-care Cancer Screening Introduction
11.8.4 Danaher Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.8.5 Danaher Recent Development
11.9 NOVIGENIX SA
11.9.1 NOVIGENIX SA Company Detail
11.9.2 NOVIGENIX SA Business Overview
11.9.3 NOVIGENIX SA Point-of-care Cancer Screening Introduction
11.9.4 NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.9.5 NOVIGENIX SA Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Detail
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Point-of-care Cancer Screening Introduction
11.10.4 Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.10.5 Quidel Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Point-of-care Cancer Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Image Screening
Table 4. Key Players of Others
Table 5. Global Point-of-care Cancer Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Point-of-care Cancer Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Point-of-care Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Point-of-care Cancer Screening Market Share by Region (2018-2023)
Table 9. Global Point-of-care Cancer Screening Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Point-of-care Cancer Screening Market Share by Region (2024-2029)
Table 11. Point-of-care Cancer Screening Market Trends
Table 12. Point-of-care Cancer Screening Market Drivers
Table 13. Point-of-care Cancer Screening Market Challenges
Table 14. Point-of-care Cancer Screening Market Restraints
Table 15. Global Point-of-care Cancer Screening Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Point-of-care Cancer Screening Market Share by Players (2018-2023)
Table 17. Global Top Point-of-care Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Cancer Screening as of 2022)
Table 18. Ranking of Global Top Point-of-care Cancer Screening Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Point-of-care Cancer Screening Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Point-of-care Cancer Screening Product Solution and Service
Table 22. Date of Enter into Point-of-care Cancer Screening Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point-of-care Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Point-of-care Cancer Screening Revenue Market Share by Type (2018-2023)
Table 26. Global Point-of-care Cancer Screening Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Point-of-care Cancer Screening Revenue Market Share by Type (2024-2029)
Table 28. Global Point-of-care Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Point-of-care Cancer Screening Revenue Market Share by Application (2018-2023)
Table 30. Global Point-of-care Cancer Screening Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Point-of-care Cancer Screening Revenue Market Share by Application (2024-2029)
Table 32. North America Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Point-of-care Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Point-of-care Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Point-of-care Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Point-of-care Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Point-of-care Cancer Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Point-of-care Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Point-of-care Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Point-of-care Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
Table 47. Hologic Corporation Company Detail
Table 48. Hologic Corporation Business Overview
Table 49. Hologic Corporation Point-of-care Cancer Screening Product
Table 50. Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 51. Hologic Corporation Recent Development
Table 52. Abbott Laboratories Company Detail
Table 53. Abbott Laboratories Business Overview
Table 54. Abbott Laboratories Point-of-care Cancer Screening Product
Table 55. Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 56. Abbott Laboratories Recent Development
Table 57. Qiagen N.V. Company Detail
Table 58. Qiagen N.V. Business Overview
Table 59. Qiagen N.V. Point-of-care Cancer Screening Product
Table 60. Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 61. Qiagen N.V. Recent Development
Table 62. F Hoffmann-La Roche Company Detail
Table 63. F Hoffmann-La Roche Business Overview
Table 64. F Hoffmann-La Roche Point-of-care Cancer Screening Product
Table 65. F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 66. F Hoffmann-La Roche Recent Development
Table 67. BD Company Detail
Table 68. BD Business Overview
Table 69. BD Point-of-care Cancer Screening Product
Table 70. BD Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 71. BD Recent Development
Table 72. Quest Diagnostics Company Detail
Table 73. Quest Diagnostics Business Overview
Table 74. Quest Diagnostics Point-of-care Cancer Screening Product
Table 75. Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 76. Quest Diagnostics Recent Development
Table 77. OncoHealth Corp Company Detail
Table 78. OncoHealth Corp Business Overview
Table 79. OncoHealth Corp Point-of-care Cancer Screening Product
Table 80. OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 81. OncoHealth Corp Recent Development
Table 82. Danaher Company Detail
Table 83. Danaher Business Overview
Table 84. Danaher Point-of-care Cancer Screening Product
Table 85. Danaher Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 86. Danaher Recent Development
Table 87. NOVIGENIX SA Company Detail
Table 88. NOVIGENIX SA Business Overview
Table 89. NOVIGENIX SA Point-of-care Cancer Screening Product
Table 90. NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 91. NOVIGENIX SA Recent Development
Table 92. Quidel Corporation Company Detail
Table 93. Quidel Corporation Business Overview
Table 94. Quidel Corporation Point-of-care Cancer Screening Product
Table 95. Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023) & (US$ Million)
Table 96. Quidel Corporation Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-care Cancer Screening Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Point-of-care Cancer Screening Market Share by Type: 2022 VS 2029
Figure 3. Genetic Screening Features
Figure 4. Image Screening Features
Figure 5. Others Features
Figure 6. Global Point-of-care Cancer Screening Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Point-of-care Cancer Screening Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Point-of-care Cancer Screening Report Years Considered
Figure 12. Global Point-of-care Cancer Screening Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Point-of-care Cancer Screening Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Point-of-care Cancer Screening Market Share by Region: 2022 VS 2029
Figure 15. Global Point-of-care Cancer Screening Market Share by Players in 2022
Figure 16. Global Top Point-of-care Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Cancer Screening as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Point-of-care Cancer Screening Revenue in 2022
Figure 18. North America Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Point-of-care Cancer Screening Market Share by Country (2018-2029)
Figure 20. United States Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Point-of-care Cancer Screening Market Share by Country (2018-2029)
Figure 24. Germany Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Point-of-care Cancer Screening Market Share by Region (2018-2029)
Figure 32. China Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Point-of-care Cancer Screening Market Share by Country (2018-2029)
Figure 40. Mexico Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Point-of-care Cancer Screening Market Share by Country (2018-2029)
Figure 44. Turkey Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Point-of-care Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Hologic Corporation Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 47. Abbott Laboratories Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 48. Qiagen N.V. Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 49. F Hoffmann-La Roche Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 50. BD Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 51. Quest Diagnostics Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 52. OncoHealth Corp Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 53. Danaher Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 54. NOVIGENIX SA Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 55. Quidel Corporation Revenue Growth Rate in Point-of-care Cancer Screening Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ポイントオブケア＆迅速診断のグローバル市場展望 2023年-2029年：迅速検査、分子診断
  • 乳がん検診装置の世界市場インサイト・予測（～2028年）
  • 婦人科がん検診装置のグローバル市場展望 2023年-2029年：赤外線サーマルイメージング、蛍光、電気インピーダンスマップ、画像識別
  • hERGスクリーニングの世界市場2023年：遺伝子型KCNH2、変異型KCNH2
  • 大腸がん分子診断学の世界市場2023年：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA6561 )"ポイントオブケア（POC）がんスクリーニングの世界市場2023年：遺伝子検査、画像検査、その他" (英文：Global Point-of-care Cancer Screening Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。